Bob Yedid | Managing Director LifeSci Advisors |
William Annett | President and Chief Executive Officer |
Mitch Levine | Chief Financial Officer |
Lyndal Hesterberg | Senior Vice President, Research and Development |
Paul Knight | Janney |
Bruce Jackson | The Benchmark Company |
Keay Nakae | Chardan |
Greetings and welcome to the OncoCyte Corporation Third Quarter Conference Call. [Operator Instructions] It is now my pleasure to introduce your host Bob Yedid. Please go ahead.
Thank you, Stacy and thank you everyone for joining this afternoon's conference call to discuss OncoCyte's third quarter 2018 financial results and recent operating highlights.
If you have not seen today's financial results press releases, please visit OncoCyte's website at www.oncocyte.com.